[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.65.227. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Research Letter
February 2016

Comparison of Radiation Doses and Best-Practice Use for Myocardial Perfusion Imaging in US and Non-US LaboratoriesFindings From the IAEA (International Atomic Energy Agency) Nuclear Cardiology Protocols Study

Author Affiliations
  • 1Division of Cardiology, Department of Medicine, Columbia University Medical Center, New York–Presbyterian Hospital, New York, New York
  • 2Section of Nuclear Medicine and Diagnostic Imaging, Division of Human Health, International Atomic Energy Agency (IAEA), Vienna, Austria
  • 3Department of Cardiology, Houston Methodist DeBakey Heart and Vascular Center, Houston, Texas
  • 4Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia
  • 5Radiation Protection of Patients Unit, IAEA, Vienna, Austria
  • 6Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston
  • 7Department of Radiology, Columbia University Medical Center, New York–Presbyterian Hospital, New York, New York
JAMA Intern Med. 2016;176(2):266-269. doi:10.1001/jamainternmed.2015.7102

Myocardial perfusion imaging (MPI) is integral to the diagnosis and management of known or suspected coronary artery disease1,2 and is therefore performed on millions of US patients each year. However, the associated exposure to ionizing radiation has raised concerns about potential radiation-related health effects. The recent cross-sectional study of MPI practice conducted by the International Atomic Energy Agency (IAEA) demonstrated significant variations in radiation doses, and in the use of best practices that can help to reduce dose, among laboratories worldwide.3 Although survey data have described self-reported US use of different MPI protocols and some dose-reduction methods,4 no previous study, to our knowledge, has characterized actual US MPI radiation doses as well as use of best practices. We compared actual MPI practice and radiation doses in US and non-US laboratories and identified opportunities to improve radiation doses in the United States.

First Page Preview View Large
First page PDF preview
First page PDF preview
×